Statin Use May Benefit Patients Hospitalized With COVID-19
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
Outpatient azithromycin use is associated with an increased risk for cardiovascular and noncardiovascular mortality.
An adverse childhood family environment is associated with cardiovascular disease incidence and all-cause mortality later in life.
Adults with congenital heart disease are more likely to have impaired functional status, biomarker profiles indicative of systemic inflammation and heart failure, and increased risk for death or cardiovascular events if they have major depression.
The American College of Cardiology announced that it will start collecting data from 2 registries on patients with novel coronavirus 2019 and heart disease.
Overall, 11.4 percent of adults had high total cholesterol during 2015 to 2018.
Researchers found that risk factors differ between various first manifestations of cardiovascular disease in patients with type 1 diabetes.
Higher nighttime blood pressure may exacerbate the detrimental effects of hypertension on cerebrovascular health and cognitive abilities among middle-aged individuals.
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Air pollution contributes significantly to global excess mortality and loss of life expectancy, particularly mortality attributable to cardiovascular disease.